Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Inference of Transcriptional Regulation From STARR-seq Data

View through CrossRef
Abstract One of the primary regulatory processes in cells is transcription, during which RNA polymerase II (Pol-II) transcribes DNA into RNA. The binding of Pol-II to its site is regulated through interactions with transcription factors (TFs) that bind to DNA at enhancer cis-regulatory elements. Measuring the enhancer activity of large libraries of distinct DNA sequences is now possible using Massively Parallel Reporter Assays (MPRAs), and computational methods have been developed to identify the dominant statistical patterns of TF binding within these large datasets. Such methods are global in their approach and may overlook important regulatory sites which function only within the local context. Here we introduce a method for inferring functional regulatory sites (their number, location and width) within an enhancer sequence based on measurements of its transcriptional activity from an MPRA method such as STARR-seq. The model is based on a mean-field thermodynamic description of Pol-II binding that includes interactions with bound TFs. Our method applied to simulated STARR-seq data for a variety of enhancer architectures shows how data quality impacts the inference and also how it can find local regulatory sites that may be missed in a global approach. We also apply the method to recently measured STARR-seq data on androgen receptor (AR) bound sequences, a TF that plays an important role in the regulation of prostate cancer. The method identifies key regulatory sites within these sequences which are found to overlap with binding sites of known co-regulators of AR. 1 Author Summary We present an inference method for identifying regulatory sites within a putative DNA enhancer sequence, given only the measured transcriptional output of a set of overlapping sequences using an assay like STARR-seq. It is based on a mean-field thermodynamic model that calculates the binding probability of Pol-II to its promoter and includes interactions with sites in the DNA sequence of interest. By maximizing the likelihood of the data given the model, we can infer the number of regulatory sites, their locations, and their widths. Since it is a local model, it can in principle find regulatory sites that are important within a local context that may get missed in a global fit. We test our method on simulated data of simple enhancer architectures and show that it is able to find only the functional sites. We also apply our method to experimental STARR-seq data from 36 androgen receptor bound DNA sequences from a prostate cancer cell line. The inferred regulatory sites overlap known important regulatory motifs and their ChIP-seq data in these regions. Our method shows potential at identifying locally important functional regulatory sites within an enhancer given only its measured transcriptional output.
Title: Inference of Transcriptional Regulation From STARR-seq Data
Description:
Abstract One of the primary regulatory processes in cells is transcription, during which RNA polymerase II (Pol-II) transcribes DNA into RNA.
The binding of Pol-II to its site is regulated through interactions with transcription factors (TFs) that bind to DNA at enhancer cis-regulatory elements.
Measuring the enhancer activity of large libraries of distinct DNA sequences is now possible using Massively Parallel Reporter Assays (MPRAs), and computational methods have been developed to identify the dominant statistical patterns of TF binding within these large datasets.
Such methods are global in their approach and may overlook important regulatory sites which function only within the local context.
Here we introduce a method for inferring functional regulatory sites (their number, location and width) within an enhancer sequence based on measurements of its transcriptional activity from an MPRA method such as STARR-seq.
The model is based on a mean-field thermodynamic description of Pol-II binding that includes interactions with bound TFs.
Our method applied to simulated STARR-seq data for a variety of enhancer architectures shows how data quality impacts the inference and also how it can find local regulatory sites that may be missed in a global approach.
We also apply the method to recently measured STARR-seq data on androgen receptor (AR) bound sequences, a TF that plays an important role in the regulation of prostate cancer.
The method identifies key regulatory sites within these sequences which are found to overlap with binding sites of known co-regulators of AR.
1 Author Summary We present an inference method for identifying regulatory sites within a putative DNA enhancer sequence, given only the measured transcriptional output of a set of overlapping sequences using an assay like STARR-seq.
It is based on a mean-field thermodynamic model that calculates the binding probability of Pol-II to its promoter and includes interactions with sites in the DNA sequence of interest.
By maximizing the likelihood of the data given the model, we can infer the number of regulatory sites, their locations, and their widths.
Since it is a local model, it can in principle find regulatory sites that are important within a local context that may get missed in a global fit.
We test our method on simulated data of simple enhancer architectures and show that it is able to find only the functional sites.
We also apply our method to experimental STARR-seq data from 36 androgen receptor bound DNA sequences from a prostate cancer cell line.
The inferred regulatory sites overlap known important regulatory motifs and their ChIP-seq data in these regions.
Our method shows potential at identifying locally important functional regulatory sites within an enhancer given only its measured transcriptional output.

Related Results

MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
ATAC-STARR-seq v1
ATAC-STARR-seq v1
Transcriptional enhancers control cell-type specific gene expression in humans and dysfunction can lead to debilitating diseases, including cancer. Identifying bona-fide enhancers ...
ATAC-STARR-seq v1
ATAC-STARR-seq v1
Transcriptional enhancers control cell-type specific gene expression in humans and dysfunction can lead to debilitating diseases, including cancer. Identifying bona-fide enhancers ...
Benchmarking Algorithms for Gene Set Scoring of Single-cell ATAC-seq Data
Benchmarking Algorithms for Gene Set Scoring of Single-cell ATAC-seq Data
AbstractGene set scoring (GSS) has been routinely conducted for gene expression analysis of bulk or single-cell RNA-seq data, which helps to decipher single-cell heterogeneity and ...
Generating Synthetic Single Cell Data from Bulk RNA-seq Using a Pretrained Variational Autoencoder
Generating Synthetic Single Cell Data from Bulk RNA-seq Using a Pretrained Variational Autoencoder
AbstractSingle cell RNA sequencing (scRNA-seq) is a powerful approach which generates genome-wide gene expression profiles at single cell resolution. Among its many applications, i...
Mediator kinase submodule-dependent regulation of cardiac transcription
Mediator kinase submodule-dependent regulation of cardiac transcription
<p>Pathological cardiac remodeling results from myocardial stresses including pressure and volume overload, neurohumoral activation, myocardial infarction, and hypothyroidism...
BasicSTARRseq: a Bioconductor R-package for analyzing STARR-seq data
BasicSTARRseq: a Bioconductor R-package for analyzing STARR-seq data
Self-transcribing active regulatory region sequencing (STARR-seq) was first described in 2013 by Arnold et al. and allows to identify and quantify enhancer regions in non-coding DN...
Abstract P1-05-23: Utilities and challenges of RNA-Seq based expression and variant calling in a clinical setting
Abstract P1-05-23: Utilities and challenges of RNA-Seq based expression and variant calling in a clinical setting
Abstract Introduction Variant calling based on DNA samples has been the gold standard of clinical testing since the advent of Sanger sequencing. The u...

Back to Top